Goserelin
SIAL/Y0000125 - European Pharmacopoeia (EP) Reference Standard
Synonym: Goserelin acetate; [D-Ser(tBu)6,Azagly10]-LHRH acetate salt
CAS Number: 145781-92-6
Empirical Formula (Hill Notation): C59H84N18O14
Molecular Weight: 1269.41
MDL Number: MFCD01747329
Linear Formula: C59H84N18O14
Product Type: Chemical
API family | goserelin |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C59H84N18O14.C2H4O2/c1 |
InChI key | IKDXDQDKCZPQSZ-JHYYTBFNSA |
manufacturer/tradename | EDQM |
SMILES string | CC(O)=O.CC(C)C[C@H](NC(=O |
storage temp. | −20°C |
Amino Acid Sequence: | Glp-His-Trp-Ser-Tyr-Ser(t |
Application: | Goserelin EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia. |
Biochem/physiol Actions: | Goserelin is a synthetic analog of LHRH (leutinizing hormone releasing hormone). Goserelin is a LHRH agonist It is used in prostate cancer and breast cancer therapies and also in the treatment of endometriosis. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Packaging: | The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue . |
Symbol | GHS08 |
Signal word | Danger |
Hazard statements | H360 |
Precautionary statements | P201 - P202 - P280 - P308 + P313 - P405 - P501 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | −20°C |
UNSPSC | 41116107 |